-
European Giants Knocked Out, Uruguay Fail to Get Out of Group Stage: FIFA World Cup 2026 Underachievers
The 2026 FIFA World Cup has produced numerous surprises and none of them would have shocked the international footballing world as two European giants, Germany and the Netherlands, crashed out of the tournament at the Round of 32 stage. Julian Nagelsmann’s men lost to Paraguay on penalties While teams like Egypt, Cape Verde,…
-
GAC Group to Celebrate 30 Million Global Users on July 16
GUANGZHOU, China, July 12, 2026 /PRNewswire/ — From the roll-off of its first vehicle to the upcoming milestone of its 30 millionth finished automobile, every step forward taken by GAC stems from the choices and trust of users worldwide. On July 16, GAC Group will stage a grand appreciation event for its 30 million users, celebrating…
-
UK businesses drastically overestimate their AI progress
EXL’s 2026 UK Enterprise AI Study finds that while most companies think they’re ahead of the competition at AI, few actually see results at scale July 08, 2026 05:03 ET | Source: EXL 75% of companies believe they are ahead of their competitors on AI, but just 12% meet the criteria to qualify as an…
-
CCTV+: Hello, Beijing! Where Ancient Meets Modern
BEIJING, July 6, 2026 /PRNewswire/ — What happens when Beijing’s ancient heritage meets its future-facing energy? Starting from the Mutianyu section of the Great Wall, this journey gives an unexpected view of the city: technology, village aesthetics, hidden spaces, and a global stage. In just one day, discover a Beijing that is more than history…
-
Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program
HALIFAX, Nova Scotia, July 03, 2026 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases today announced that it has received a Notice of Termination for Convenience from the National Institute of Allergy and Infectious Diseases (“NIAID”), part of the…
-
Morepen Starts Commercial Supplies Under its Rs. 825 Crore CDMO Mandate; First Rs. 50 Crore Dispatch Already Completed in Q1FY2026-27
Gurugram, Haryana, India Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) today issued an update on its recently announced Rs. 825 crore CDMO mandate. The first commercial dispatch, valued at approximately Rs. 50 crore, has already been completed by the company under the program during Q1FY2026-27. This marks the successful transition of the mandate from validation…
-
TACO BELL® LAUNCHES L.O.C.O.S., ITS FIRST EMOTIONAL SUPPORT TACO PLATFORM FOR FANS IN THEIR FEELS
Debuting during this summer’s biggest sports stage, L.O.C.O.S. (Loss Or Celebration Outcome Support) rewards fans with tacos when they need them most, turning culture’s biggest wins and losses into a global emotional support taco program. TLDR: From celebrating a win to days that go fully off the rails, fans already turn to Taco Bell when…
-
Dyne Therapeutics Appoints Barry Greene to Board of Directors
June 22, 2026 16:10 ET | Source: Dyne Therapeutics, Inc. WALTHAM, Mass., June 22, 2026 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the appointment of Barry Greene to its Board of Directors. Mr. Greene brings more…
-
Resolution Therapeutics extends inflammatory and fibrotic disease pipeline with in vivo Regenerative Macrophage Therapy
Material Transfer Agreements provide access to leading lipid nanoparticle formulations to validate delivery of its proprietary payloads and accelerate development of in vivo Regenerative Macrophage Therapy Development programme complements Company’s autologous engineered Regenerative Macrophage Therapy, RTX001, in Ph 1/2 clinical development Together, programmes aim to broaden patient population able to benefit from Regenerative Macrophage Therapy…
-
Bybit Launches Football Season 2026 Campaign With Up To $1 Million Prize Pool
DUBAI, UAE, June 9, 2026 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, has announced the launch of its Football Season 2026 campaign, a multi-stage trading and prediction event centered on the theme “The Pitch is Everywhere,” where users can trade, predict and share a prize pool of up to $1 million in…
-
Exploratory Efficacy Data Suggests Further Study of Peanut Tolerance with Oral Mucosal Immunotherapy (OMIT)
NEW YORK, June 12, 2026 (GLOBE NEWSWIRE) — Intrommune Therapeutics, Inc., a clinical-stage biotechnology company committed to developing a patient-friendly treatment platform for people with peanut and other food allergies, today announced the presentation of exploratory efficacy data from the Oral Mucosal Escalation Goal Assessment (OMEGA) Phase 1 safety trial at the 2026 Eastern Allergy…
-
Crypto Market News: AlphaPepe To Announce First CEX Partnership as XRP Price Prediction Hits $8.00
MONACO, June 04, 2026 (GLOBE NEWSWIRE) — Crypto market news is turning toward AlphaPepe after the project confirmed that its first centralized exchange partnership reveal is now expected within weeks. The presale has crossed $1.46 million in total capital raised, Stage 17 is live at $0.01858, and holder growth has climbed past 9,200 while AlphaSwap…
-
Marwari Catalysts Group Launches Thrive 10.0 to Empower DefenceTech and AgriTech Startups in India
Marwari Catalysts Group, focused on building founders from Tier II and Tier III cities, has announced the launch of Thrive 10.0, the latest edition of its flagship founder-support programme. This edition places a strong strategic focus on two high-impact and rapidly growing sectors in India: DefenceTech and AgriTech. MCats Group Launches Thrive 10.0 to…
-
Canovation and CANPACK Formalize Collaboration to Accelerate CanReseal® Toward Commercial Launch
The companies will align Canovation’s resealable aluminum can-end technology with CANPACK’s global manufacturing expertise to support the next stage of scale-up. FORT LAUDERDALE, Fla., June 2, 2026 /PRNewswire/ — Canovation, a packaging innovation company focused on sustainable metal container solutions, and CANPACK, a leading global manufacturer of aluminum beverage cans and packaging formats, today announced…
-
SkyFi Selected to Advance to NATO DIANA Mission Track
Earth intelligence platform is one of five companies to advance from a 150-company accelerator cohort to the program’s adoption-focused stage to support operational readiness across the Alliance AUSTIN, Texas, June 1, 2026 /PRNewswire/ — SkyFi, the leading Earth intelligence platform, today announced its selection to advance to the Mission Track of the North Atlantic Treaty…
-
Dudigital Global Limited Secures CPV Services Contract from Embassy of India, Kuwait
3-year contract strengthens recurring revenue visibility and expands GCC presence New Delhi, Delhi, India Dudigital Global Limited today announced that it has been awarded the contract for outsourcing of Consular, Passport and Visa services by the Embassy of India, Kuwait, following a two-stage competitive bidding process. The contract is valid for a period of three…
-
Crypto News Today: AlphaPepe Hits $1.38M Raised While Bitcoin Price Prediction Targets $250K
MONACO, May 30, 2026 (GLOBE NEWSWIRE) — Crypto news today is turning toward AlphaPepe after the project announced that its presale has crossed $1.38 million in total capital raised. Stage 17 is live at $0.01804 per token, the holder count has passed 9,000, the AlphaSwap AI DEX demo has surpassed 5,000 active users, and AlphaPepe…
-
Immatics Presents Data on IMA401 MAGEA4/8 Bispecific at 2026 ASCO Annual Meeting with Simultaneous Publication in Nature Medicine Supporting Development of IMA401/IMA402 Combination in Lung Cancer
IMA401 achieved deep and durable responses in various indications, including melanoma and head and neck cancer, with an initial promising clinical signal observed in lung cancer In head and neck cancer, IMA401 treatment at recommended Phase 2 dose (RP2D) with or without pembrolizumab resulted in a 29% confirmed ORR (4/14), 64% DCR (9/14) and mDOR…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
